Astrantus’s Intuitive Surgical ISRG Stock Holding History

Astrantus’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,100	Closed	-$1.11M	–	238
2021 Q4	$1.11M	Buy	+3,100	New	+$1.07M	0.83%	30

Other funds holding ISRG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Astrantus's ISRG Position: Q1 2022 in Review

Astrantus sold out of Intuitive Surgical (ISRG) in Q1 2022, closing a stake of 3,100 shares — an estimated $1.11M sold.

Astrantus first reported a position in ISRG in Q4 2021 and held it in 1 quarter. The position peaked at $1.11M in Q4 2021. 1,468 funds tracked by Wall St. Rank hold ISRG as of Q1 2022.

Astrantus reported no remaining Intuitive Surgical position as of Q1 2022 after selling out during the quarter.
Astrantus sold 3,100 Intuitive Surgical shares in Q1 2022, an estimated $1.11M.
Astrantus first reported a position in Intuitive Surgical in Q4 2021 and held it in 1 quarter.
Astrantus's Intuitive Surgical position peaked at $1.11M in Q4 2021.
1,468 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.